Michael Caruana
Overview
Explore the profile of Michael Caruana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wade S, Sarich P, Vaneckova P, Behar-Harpaz S, Ngo P, Grogan P, et al.
Stat Methods Med Res
. 2025 Feb;
:9622802241310326.
PMID: 39936347
Simulation models of smoking behaviour provide vital forecasts of exposure to inform policy targets, estimates of the burden of disease, and impacts of tobacco control interventions. A key element of...
2.
Lew J, Luo Q, Worthington J, Ge H, He E, Steinberg J, et al.
Med Decis Making
. 2025 Feb;
:272989X251314050.
PMID: 39915917
Background: Changing colorectal cancer (CRC) incidence rates, including recent increases for people younger than 50 y, need to be considered in planning for future cancer control and screening initiatives. Reliable...
3.
Shah R, Hanna N, Loo C, David M, Mafra A, Fink H, et al.
Nat Cancer
. 2025 Jan;
6(1):194-204.
PMID: 39747650
The coronavirus disease 2019 pandemic substantially impacted the delivery of cancer services and programs. Here we reviewed and synthesized the global scale and impact of pandemic-related delays and disruptions on...
4.
Wade S, Ngo P, He Y, Caruana M, Steinberg J, Luo Q, et al.
Public Health Res Pract
. 2024 Dec;
PMID: 39694854
Australia's National Lung Cancer Screening Program will commence in July 2025, targeted at individuals aged 50-70 years with a 30 pack-year smoking history (equivalent to 20 cigarettes per day for...
5.
Salisbury A, Ciardi J, Norman R, Smit A, Cust A, Low C, et al.
Appl Health Econ Health Policy
. 2024 Jun;
PMID: 38916649
Purpose: Genetic and genomic testing can provide valuable information on individuals' risk of chronic diseases, presenting an opportunity for risk-tailored disease screening to improve early detection and health outcomes. The...
6.
Shah R, Loo C, Hanna N, Hughes S, Mafra A, Fink H, et al.
J Cancer Policy
. 2024 Jun;
41:100486.
PMID: 38830535
During the COVID-19 pandemic, countries adopted mitigation strategies to reduce disruptions to cancer services. We reviewed their implementation across health system functions and their impact on cancer diagnosis and care...
7.
Worthington J, Sun Z, Fu R, Lew J, Chan K, Li Q, et al.
PLoS One
. 2024 Apr;
19(4):e0296945.
PMID: 38557758
COVID-19 disrupted cancer control worldwide, impacting preventative screening, diagnoses, and treatment services. This modelling study estimates the impact of disruptions on colorectal cancer cases and deaths in Canada and Australia,...
8.
Luo Q, Steinberg J, Kahn C, Caruana M, Grogan P, Page A, et al.
Lancet Reg Health West Pac
. 2024 Mar;
43:100987.
PMID: 38456088
Background: Long-term projections of premature mortality (defined as deaths age <75 years) help to inform decisions about public health priorities. This study aimed to project premature mortality rates in Australia...
9.
Hall M, Simms K, Murray J, Keane A, Nguyen D, Caruana M, et al.
Nat Med
. 2023 Dec;
29(12):3059-3066.
PMID: 38087116
To support a strategy to eliminate cervical cancer as a public health problem, the World Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical pre-cancerous lesions in...
10.
Simms K, Keane A, Thi Ngoc Nguyen D, Caruana M, Hall M, Lui G, et al.
Nat Med
. 2023 Dec;
29(12):3050-3058.
PMID: 38087115
In 2020, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer as a public health problem. To support the strategy, the WHO published updated cervical screening guidelines...